Debt to Equity Ratio Chart

View Debt to Equity Ratio for EOLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2016. Start Trial.
Date Value
June 30, 2026 -5.333
March 31, 2026 -5.730
December 31, 2025 -6.708
September 30, 2025 -5.386
June 30, 2025 -8.305
March 31, 2025 -19.72
December 31, 2024 23.54
September 30, 2024 22.05
June 30, 2024 6.563
March 31, 2024 6.867
December 31, 2023 -6.117
September 30, 2023 -5.238
June 30, 2023 -13.91
March 31, 2023 10.70
December 31, 2022 4.023
September 30, 2022 2.55
June 30, 2022 1.592
March 31, 2022 1.110
December 31, 2021 0.043
September 30, 2021 0.2432
Date Value
June 30, 2021 0.2224
March 31, 2021 1.010
December 31, 2020 -1.896
September 30, 2020 3.918
June 30, 2020 2.233
March 31, 2020 1.549
December 31, 2019 1.215
September 30, 2019 5.637
June 30, 2019 2.318
March 31, 2019 1.202
December 31, 2018 0.2003
September 30, 2018 0.7149
June 30, 2018 1.721
March 31, 2018 1.092
December 31, 2017 -2.797
September 30, 2017 -2.637
June 30, 2017 -2.851
March 31, 2017
December 31, 2016 -8.410

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945
Johnson & Johnson 0.5771
Eli Lilly & Co. 1.621

Debt to Equity Ratio Related Metrics